This inventor holds 32 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Medshine Discovery Inc., Genentech, Inc., Amlogic (Shanghai) Co., Ltd.. Active years: 2016-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jiangsu, CN (2021)
- Lianyungang, CN (2022)
- Shanghai, CN (2016 - 2024)
Company Filing History:
7 out of 72 
6 out of 3,300 
4 out of 54 
Years Active: 2016-2026
Areas of Expertise:
Title: **Kevin X Chen: Innovator in Pharmaceutical Patents**
Introduction
Kevin X Chen is an esteemed inventor based in Shanghai, China, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 27 patents, Chen has dedicated his career to developing innovative compounds that address critical healthcare needs.
Latest Patents
Among his latest innovations, Chen has developed two noteworthy patents. The first, titled “Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof,” focuses on a group of compounds that act as selective inhibitors for HER2, a protein involved in some aggressive forms of breast cancer. This invention details a compound represented by a specific formula, aiming to contribute to the development of efficacious HER2-targeted therapies.
The second patent, “Anti-influenza virus pyrimidine derivative,” discloses a class of compounds designed to combat influenza viruses. This invention highlights the potential for these newly identified derivatives to be utilized in the formulation of drugs that could effectively treat influenza-related diseases.
Career Highlights
Kevin X Chen has worked with reputable organizations such as Medshine Discovery Inc. and Genentech, Inc., where he contributed to groundbreaking research and development efforts. His experience across these companies has allowed him to harness his skills in pharmaceutical innovation while driving forward the frontiers of drug development.
Collaborations
Throughout his career, Chen has collaborated with eminent individuals in the pharmaceutical field, including Shuhui Chen and Jian Li. These collaborations have fostered an environment of innovation and excellence, propelling them together into the realm of noteworthy scientific advancements.
Conclusion
Kevin X Chen's work exemplifies the impact of dedicated innovation in the pharmaceutical industry. His extensive patent portfolio reflects a commitment to advancing healthcare through science, and his collaborative efforts highlight the importance of teamwork in achieving success in complex research endeavors. As he continues to explore new frontiers, Chen remains a pivotal figure in the landscape of modern medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile